NFYA and non-small cell lung carcinoma: Secondly, PANDAR has been shown to promote cell survival in non-small cell lung carcinoma (NSCLC) in which low expression level of PANDAR permits NF-YA to up-regulate Bcl2 expression, an anti-apoptotic gene [62].